[Thrombosis in various diseases: myeloproliferative disorders].
D001241:Aspirin / Q000627:therapeutic use; D001779:Blood Coagulation Factors / Q000032:analysis; D002066:Busulfan / Q000627:therapeutic use; D002225:Carbazilquinone / Q000627:therapeutic use; D004176:Dipyridamole / Q000627:therapeutic use; D006801:Humans; D009196:Myeloproliferative Disorders / Q000097:blood / Q000150:complications*; D010977:Platelet Factor 3 / Q000032:analysis; D010978:Platelet Factor 4 / Q000032:analysis; D013927:Thrombosis / Q000209:etiology* / Q000517:prevention & control; D001620:beta-Thromboglobulin / Q000032:analysis
D001779:Blood Coagulation Factors; D001620:beta-Thromboglobulin; D002225:Carbazilquinone; D010977:Platelet Factor 3; D010978:Platelet Factor 4; D004176:Dipyridamole; D002066:Busulfan; D001241:Aspirin